Article
COPD Foundation links arms with Ena on antiviral nasal spray ahead of phase 2 trials in COVID-19, flu
Rating:
0.0
Views:
56
Likes:
1
Library:
1
The COPD Foundation has steppe | The COPD Foundation has stepped up to support development of Ena Respiratory's antiviral nasal spray for use in people with chronic lung diseases. Ena is preparing to run phase 2 studies to test the ability of the nasal spray to prevent COVID-19 and influenza.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value